{
  "report_rows": [
    {
      "kpi": "Operating EPS",
      "prediction": "BEAT",
      "answer": "pred ~$2.49 vs. cons $2.43",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Operating EBITDA",
      "prediction": "BEAT",
      "answer": "pred ~$2.31B vs. cons $2.27B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Net sales",
      "prediction": "BEAT",
      "answer": "pred ~$6.73B vs. cons $6.63B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 operating EBITDA guidance",
      "prediction": "BETTER",
      "answer": "guide ~$4.25B midpoint vs. cons $4.20B midpoint (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 operating EPS guidance",
      "prediction": "BETTER",
      "answer": "guide ~$3.80 midpoint vs. cons $3.74 midpoint (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Separation net dis-synergies",
      "prediction": "BETTER",
      "answer": "guide ~$75M vs. cons $90M (FY26)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 4.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 6.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "The ~$0.06 FY26 EPS midpoint increase versus ~$3.74 consensus and ~$0.05B EBITDA midpoint increase versus ~$4.20B consensus support upward out-period revisions; a lower ~$75M separation-dis-synergy outlook versus ~$90M expected adds valuation support.",
  "day5_confidence": "MEDIUM"
}